Carolina Liquid Chemistries Successfully Launches High Speed Benchtop Analyzer

0

Carolina Liquid Chemistries Corp.

FOR IMMEDIATE RELEASE:

Carolina Liquid Chemistries Successfully Launches High Speed Benchtop Analyzer

GREENSBORO, N.C. (June 26, 2018) – Carolina Liquid Chemistries Corp., known for its clinical chemistry analyzers and reagents, announces the successful launch of Medica Corporation’s highspeed benchtop analyzer, the EasyRA®. The refreshed EasyRA clinical chemistry analyzer now offers double the throughput, operating at a photometric rate of up to 240 tests per hour or up to 480 tests per hour with ISE. The EasyRA urine drug screening and general chemistry reagents are CLIA categorized as moderately complex. The test menu consists of 14 urine drugs of abuse tests and 35 general chemistry tests. The EasyRA is well suited for a variety of test centers including STAT labs, physician office laboratories, pain management clinics, and urgent care centers. This all-in-one system allows clinical laboratories to screen for drugs of abuse in urine while also allowing healthcare providers to assess routine chemistry panels including CMPs, lipids and liver enzymes on a single, easy-to-use analyzer.

High Speed Benchtop Analyzer

Carolina Liquid Chemistries Successfully Launches High Speed Benchtop Analyzer

Contact: Matt Joy Carolina Liquid Chemistries Corp.

Phone: 1-800-722-8910 Ext.103 or Email: mjoy@carolinachemistries.com

About Carolina Liquid Chemistries Corp. Headquartered in Greensboro, N.C., Carolina Liquid Chemistries is a diagnostic company that is a privately held, veteran owned, ISO certified and an FDA registered manufacturer, repackager and relabeller. For 20 years, CLC has provided laboratories worldwide with high quality clinical chemistry instruments and reagents. Carolina Liquid Chemistries is a single source for instruments, reagents, installation, training and service. For more information, visit http://www.carolinachemistries.com

Share.

263 words

About Author

Leave A Reply

Log in or register to comment on this article.